Born and raised in Hannover, Lower Saxony follows social and economic developments around the globe. The large number of journeys and participation in events have enabled him to build up a personal network.
As a passionate entrepreneur and columnist he explains and compares the most diverse business models as well as markets for interested stock traders. Besides precious metals and energy sources, innovations from various industries are of particular interest.
Since the 1990s, extensive experience in the capital market from various perspectives has been gained. The anecdotes from this time are now paired with the expert knowledge from his business studies in the current commentaries in an entertaining way.
Commented by Mario Hose
Commented by Mario Hose on August 24th, 2020 | 06:58 CEST
BioNTech, CureVac, Valeo Pharma - the license to print money
Those who solve problems or create desires can usually earn a lot of money. One of the most important requirements is that the solution is scalable and can be sold in large quantities. The solutions around the Corona pandemic are a particularly lucrative business, because there is enormous pressure to act from all sides. The sooner vaccines or other products are available, the sooner it will be possible to return to normal everyday life. While two German pharmaceutical companies are investing a lot of money in researching a vaccine, a Canadian competitor is taking an equally exciting and less risky route.
ReadCommented by Mario Hose on August 21st, 2020 | 08:00 CEST
BP, Saturn Oil & Gas, Shell - why this share is now interesting
The Corona pandemic is still keeping politics and business busy. The restrictions in everyday life are causing many changes for people. An end to the situation is not yet in sight and therefore great hope is being placed in the development of a vaccine against Covid-19. Those who want to position themselves for the time after this phase have excellent opportunities with the oil sector, one of the largest markets in the world.
ReadCommented by Mario Hose on August 20th, 2020 | 08:29 CEST
EQS Group, EXMceuticals, Media and Games Invest - Buy recommendations from the experts
Analysts' reports on listed companies serve investors as an external source of information. As a rule, research houses publish their recommendations in connection with financing, the publication of financial statements or in order to increase awareness. The information is usually freely accessible so that as broad a public as possible can form an opinion about the company. For orientation, analysts give a price target within a time window and a rating, which can be 'buy', 'hold' or 'sell', for example.
ReadCommented by Mario Hose on August 19th, 2020 | 08:20 CEST
dynaCERT, TUI, Varta - where is it worth investing now?
The Corona Pandemic has changed society and the economy in recent months. Topics such as social distancing did not exist in this extreme way before and has, for example, turned the travel industry upside down. As a result of government rescue measures, airlines and travel companies had to be provided with liquidity so that the systemically important corporations did not slip into insolvency through no fault of their own and much larger and more uncontrollable losses were caused by a domino effect. But a lot has also happened in the technology sector and there are exciting developments that can be lucrative for investors.
ReadCommented by Mario Hose on August 18th, 2020 | 06:00 CEST
BioNTech, CureVac, Valeo Pharma - who is the Covid-19 winner?
The two German companies BioNTech and CureVac have already provided investors with a considerable boost in share prices. The companies have come into the public eye in recent months because they are working on a vaccine against Covid-19 and have already made great progress. Worldwide, these two companies belong to the elite in research and are a beacon of hope in the fight against the corona pandemic. While BioNTech has been listed on the stock exchange for some time, CureVac made its stock market debut last Friday - with success. Investors who have so far missed their entry in these companies should have Valeo Pharma at least on their watch list.
ReadCommented by Mario Hose on August 17th, 2020 | 08:00 CEST
Barrick Gold, Desert Gold, SolGold - Buffett's Berkshire gives the starting signal
When on Friday evening after trading hours the news went on the tickers that one of the richest people in the world was switching from banks to gold, then this in itself would have received attention. But that of all people Warren Buffett with his investment company Berkshire Hathaway is now investing in the gold sector has a completely different quality for the investment community. Buffett has always refused to invest in gold, this new attitude towards the precious metal will be the starting signal for a rally through new investor circles. In addition to Amazon, Apple, Facebook, Google, Microsoft and Tesla, gold shares obviously also belong in the portfolio. An exciting stock market week with buying opportunities begins.
ReadCommented by Mario Hose on August 14th, 2020 | 08:07 CEST
EXMceuticals, Nebelhornbahn, Syzygy - where entry opportunities now exist
While the share prices of a variety of large companies have already returned to pre-Covid-19 price levels, the shares of small and mid-caps are often still trading at significantly lower levels. Here, there may be opportunities with price potential that can offer attractive returns for investors. It may therefore be worthwhile to take a closer look at some business models and companies.
ReadCommented by Mario Hose on August 13th, 2020 | 08:14 CEST
dynaCERT, NEL ASA, Royal Helium - benefit from the UN climate mission
Helium and hydrogen are now not only driving space travel and modern mobility, the inert gases are also the focus of investors and politicians. While Elon Musk and Richard Branson want to make space tourism possible and NASA is using SpaceX to implement extensive programmes with satellites, the demand for helium will continue to increase. Hydrogen is increasingly being discussed as an alternative to a more polluting battery as an energy storage medium. An innovation that uses hydrogen as a catalyst has now been included in the United Nations' "United 4 Smart Sustainable Cities" program: HydraGEN
ReadCommented by Mario Hose on August 12th, 2020 | 08:27 CEST
Barrick Gold, Scottie Resources, Triumph Gold - Entry chance after rally
Who would have thought that a report on a Covid-19 vaccine from Russia would bring a breather to the gold rally? Within 24 hours, the price of the precious metal slipped through the USD 2,000.00 and USD 1,900.00 markers, recording a loss in value of around USD 150.00 per troy ounce. Currently the price is trading at USD 1,880.00 and the correction is the largest since March 2020, when the panic about the spread of the Corona virus was at its highest. Gold's rise has already begun in May 2019 at below USD 1,300.00 and the current trend may offer an excellent entry opportunity.
ReadCommented by Mario Hose on August 11th, 2020 | 09:46 CEST
B2Gold, Desert Gold, Osino Resources - Gold is becoming scarce
The price of a troy ounce of gold has been quoted at over USD 2,000.00 for some time now and has thus reached historic territory. Given that fears of a decline in the value of fiat money are encouraging people to flee to the world's oldest currency, this situation is expected to continue as long as central banks and politicians implement measures to mitigate the consequences of the Corona Pandemic. The measures taken in 2020 are likely to be ten times higher than the activities related to the financial crisis in 2008/09. The value driver for gold is the fact that it cannot be produced artificially and, in addition, by 2029, annual production volumes are estimated to have fallen by 45%, which could have an additional panic effect.
Read